Authors
Robert J. Nordyke, PhD, is a Principal and Senior Advisor in the Pharmaceutical Commercialization practice at BlueRidge Life Sciences, where he leads policy research and evidence generation to support market access and value demonstration. He has over 25 years of experience across health economics, policy research, HTA, and product commercialization at drug manufacturers, consultancies, and policy research groups. Bob holds engineering degrees from Rose‑Hulman Institute of Technology and the University of Texas at Austin, and a PhD from the RAND Graduate School of Public Policy.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success
2
High-Dose Vitamin D3 Fails to Improve PFS in Phase 3 Metastatic CRC Trial
3
OneOncology Partners With OpenEvidence to Give Physicians Access Within Clinical Workflows
4
Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups
5

